common bpc 157 dosage for stacking with trt BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or Peptide Stack Guide | Perfect
Description
Staying informed about ongoing research and consulting with healthcare professionals will help you make well-informed decisions about incorporating BPC-157 into your treatment plan

Any patient with active malignancy, uncontrolled metabolic disease, or a history of endocrine tumors is not a candidate for GH-stimulating peptide therapy

doi: 10.15252/emmm.201708712 60

Safety data in humans is extremely limited because these peptides lack clinical trial evaluation for vascular applications